New issues in bacterial meningitis in adults. Antibiotic resistance has complicated treatment.
The epidemiologic factors of bacterial meningitis, a serious disease that must be addressed with great urgency, have evolved dramatically in the last 25 years. Among both adults and children, multidrug-resistant Streptococcus pneumoniae has emerged as a clinical challenge and has greatly complicated the empirical management of this disease. In this article, the author focuses on new issues involving the epidemiologic factors, diagnosis, treatment, and prevention of bacterial meningitis in adults.
Spach
David H
DH
Division of Infectious Diseases, University of Washington School of Medicine, Seattle, WA 98104, USA. spach@u.washington.edu
D000328:Adult; D019072:Antibiotic Prophylaxis; D024881:Drug Resistance, Bacterial; D006801:Humans; D016920:Meningitis, Bacterial / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology / Q000517:prevention & control; D022401:Meningococcal Vaccines; D014481:United States / Q000453:epidemiology
D022401:Meningococcal Vaccines